Skip to main content
Premium Trial:

Request an Annual Quote

Star-studded Prize

A ceremony that included appearances by Mark Zuckerberg, Benedict Cumberbatch, Cameron Diaz, and Elon Musk feted the work of the University of California, Berkeley's Jennifer Doudna, Emmanuelle Charpentier from the Helmholtz Center for Infection Research, the University of Massachusetts Medical School's Victor Ambros, and Gary Ruvkun from Massachusetts General Hospital, the Guardian reports. They all were recipients of the life sciences Breakthrough prize.

These awards were kicked off about two years ago by billionaire Yuri Milner, who argues that science should be "as glitzy as rock 'n' roll," the New York Times adds. Yuri and Julia Milner have teamed up with Facebook's Zuckerberg and Priscilla Chan along with Google's Sergey Brin and Anne Wojcicki and Alibaba's Jack Ma and Cathy Zhang to give out a dozen prizes worth a total $36 million.

"The world faces many fundamental challenges today and there are many amazing scientists, researchers and engineers helping us solve them," Zuckerberg said in a statement. "This year's Breakthrough prize winners have made discoveries that will help cure disease and move the world forward. They deserve to be recognized as heroes."

Doudna and Charpentier were honored for their work on CRISPR/Cas9, and Ambros and Ruvkun were lauded for their exploration of microRNA-based gene regulation.

Other winners included Alim Louis Benabid at the Joseph Fourier University, Rockefeller University's David Allis, and physicists Saul Perlmutter, Brian Schmidt, and Adam Riess. The mathematics prizewinners were celebrated at a separate event over the summer.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.